District health board of residence, ethnicity and socioeconomic status all impact publicly funded insulin pump uptake in New Zealand patients with type 1 diabetes
Benjamin J Wheeler, Rhiannon Braund, Barbara Galland, Anastasia Mikuscheva, Esko Wiltshire, Craig Jefferies, Michel de Lange
Insulin pump therapy is becoming increasingly common for those living with type 1 diabetes, and has been publicly funded in New Zealand since 2012. This study aimed to examine national uptake of publicly funded insulin pumps from 2012 to 2016 using data provided by the Ministry of Health. The main findings show that from 2012 to 2016 there has been a steadily increasing uptake of pumps. Despite publicly funded access, disparities in use appear to exist, including by district health board of residence as well as traditionally described socio-demographic barriers to healthcare (ethnicity, socioeconomic status, age, gender). Efforts to understand and reduce these disparities are required.